Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 0 | |
Outperform | 3 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 3 analysts offering 12 month price targets for Monopar Therapeutics Inc have a median target of 15.00, with a high estimate of 30.00 and a low estimate of 9.00. The median estimate represents a -11.14% decrease from the last price of 16.88.
High | 77.7% | 30.00 |
Med | -11.1% | 15.00 |
Low | -46.7% | 9.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 27, 2025.
Average growth rate | +14.24% |
Average growth rate | -10.51% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
Average growth rate | 0.00% |
More ▼